IMMX Immix Biopharma Inc
Company Analysis
Latest News
🔴 Immix Biopharma is trading 5% down today amid biotech-sector weakness
Immix Biopharma is trading 5.15% lower at $7.92, alongside weakness in the biotech sector. - XBI was down 2.08% during the regular session; healthcare and...
🟢 Immix Biopharma is trading 8% up in pre-market with no clear company-specific catalyst
Immix Biopharma is trading at $9.00, up +7.78%, before the October 23, 2026 open, with no clear company-specific announcement tied to the move. - The latest...
🔴 Immix Biopharma is trading 5.76% down today as biotech falls 2.06%
Immix Biopharma is trading 5.76% lower at $8.18, alongside biotech-sector weakness. - Biotech is down 2.06% during regular trading, amid broader market...
🔴 Immix Biopharma is trading 5% down today amid a 2.01% XBI decline
Immix Biopharma is trading at $8.79, down 5.03%, amid biotech-sector weakness; XBI’s decline offers a plausible, but unconfirmed, explanation. - No new...
🔴 Immix Biopharma is trading 5% down amid biotech-sector weakness
Immix Biopharma is trading at $8.98, with a -5.37% change, alongside biotech-sector weakness; no confirmed company-specific catalyst for the October 8 decline...
🔴 Immix Biopharma is trading 5.6% down with no confirmed company-specific catalyst
Immix Biopharma is trading 5.6% lower at $9.56, with no confirmed company-specific announcement explaining the decline. - Recent coverage discussed earlier...
🟢 Immix Biopharma is trading 5% up
Immix Biopharma is trading 5.32% higher at $10.20, with no confirmed company-specific catalyst explaining the October 5 move. - An October 5 report cited...
🔴 Immix Biopharma is trading 5.4% down today with no confirmed catalyst
Immix Biopharma is trading 5.43% down now at $9.68, with no clear company-specific announcement dated October 2 explaining the decline. - Recent coverage...
Immix Biopharma Announces Pricing of $125 Million Underwritten Common Stock Offering
Immix Biopharma, Inc. announced the pricing of an underwritten public offering of 11,363,637 shares of its common stock at a price of $11.00 per share. The...
🟢 Immix Biopharma is trading 5.5% up today amid broader market strength
Immix Biopharma is trading at $11.12, up +5.50%, as broader markets rise. - The S&P 500 is up 0.54% and the Nasdaq Composite is up 0.89%, pointing to a risk-on...
Immix Biopharma Sells $125 Million in New Stock to Fund Its Big Drug Bet — But Can Shareholders Stomach a Second Dilution in Four Months?
Shares of Immix Biopharma tumbled 10.8% to $10.23 after the company priced an 11.4 million-share offering at $11.00 apiece — a 4.1% discount to Friday's close...
IMMX Announces 89% Complete Response Rate in Phase 2 AL Amyloidosis Trial
Immix Biopharma announced positive interim results from its fully enrolled, 45-patient Phase 2 NEXICART-2 clinical trial for its CAR-T therapy, NXC-201, in...
🔴 Immix Biopharma is trading 11% down today after pricing a $125 million underwritten offering
Immix Biopharma is trading 10.81% lower at $10.23 after pricing a $125 million underwritten offering, creating dilution pressure. - The company will issue...
🔴 Immix Biopharma is trading 7% down today amid a $125 million stock offering
Immix Biopharma is trading at $10.68, down 6.89%, amid a newly priced stock offering. - The offering covers 11,363,637 shares at $11.00 each and is expected...
🟢 Immix Biopharma is trading 6% up today — catalyst remains unclear
Immix Biopharma is trading 5.93% higher at $11.62 on September 28, 2026; the catalyst remains unclear. - No clear company-specific announcement or catalyst was...
🔴 Immix Biopharma is trading 5.26% down today with no clear catalyst identified
Immix Biopharma is trading 5.26% lower at $11.09 after no clear company-specific announcement was identified for September 25, 2026. - Recent coverage also...
🔴 Immix Biopharma is trading 5.2% down today amid elevated yields and crude above $100
Immix Biopharma is trading 5.2% lower at $11.30, with the decline appearing mainly linked to biotech and broader-market weakness amid elevated Treasury yields...
🔴 Immix Biopharma is trading 5.3% down today as oil and Treasury yields pressure equities
Immix Biopharma is trading 5.3% lower at $12.15, with the decline appearing primarily tied to broader risk-off conditions as rising crude oil and Treasury...
🟢 Immix Biopharma is trading 5.22% up in pre-market as biotech stocks rise
Immix Biopharma is trading 5.22% up at $13.50 in pre-market amid broad biotech strength, with XBI up 2.61%. - No fresh company-specific announcement was...
🟢 Immix Biopharma is trading 5.29% up today after Mizuho raised target to $26 from $15
Immix Biopharma is trading 5.29% up at $12.58 after Mizuho maintained an Outperform rating and raised its price target to $26 from $15. • The analyst cited...